Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014 (2014), Article ID 243518, 8 pages
http://dx.doi.org/10.1155/2014/243518
Clinical Study

Relationship between HgbA1c and Myocardial Blood Flow Reserve in Patients with Type 2 Diabetes Mellitus: Noninvasive Assessment Using Real-Time Myocardial Perfusion Echocardiography

1Mayo Clinic Cardiovascular Ultrasound and Hemodynamic Laboratory, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
2Division of Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
3Division of Cardiovascular Medicine, Assiut University, Assiut 71515, Egypt

Received 28 April 2014; Accepted 9 June 2014; Published 2 July 2014

Academic Editor: Nikolaos Papanas

Copyright © 2014 Runqing Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Valenta, V. Dilsizian, A. Quercioli, H. R. Schelbert, and T. H. Schindler, “The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow,” Current Cardiology Reports, vol. 14, no. 2, pp. 217–225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Nitenberg, P. Valensi, R. Sachs, E. Cosson, J. Attali, and I. Antony, “Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors,” Diabetes Care, vol. 27, no. 1, pp. 208–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Nitenberg, I. Pham, I. Antony, P. Valensi, J. Attali, and D. Chemla, “Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: a 10 year follow-up study,” Atherosclerosis, vol. 183, no. 1, pp. 113–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. T. H. Schindler, E. U. Nitzsche, H. R. Schelbert et al., “Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events,” Journal of the American College of Cardiology, vol. 45, no. 9, pp. 1505–1512, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Ikeda, R. Iijima, H. Hara, M. Moroi, M. Nakamura, and K. Sugi, “Glycated hemoglobin is associated with the complexity of coronary artery disease, even in non-diabetic adults,” Journal of Atherosclerosis and Thrombosis, vol. 19, no. 12, pp. 1066–1072, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. American Diabetes Association, “Standards of medical care in diabetes–2006,” Diabetes Care, vol. 29, supplement 1, pp. S4–S42, 2006. View at Google Scholar
  7. G. Ravipati, W. S. Aronow, C. Ahn, K. Sujata, L. N. Saulle, and M. B. Weiss, “Association of hemoglobin A1c level with the severity of coronary artery disease in patients with diabetes mellitus,” The American Journal of Cardiology, vol. 97, no. 7, pp. 968–969, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Berry, S. Noble, J. C. Grégoire et al., “Glycaemic status influences the nature and severity of coronary artery disease,” Diabetologia, vol. 53, no. 4, pp. 652–658, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. Ayhan, M. Tosun, S. Ozturk et al., “Glycated haemoglobin is correlated with the severity of coronary artery disease independently of traditional risk factors in young patients,” Endokrynologia Polska, vol. 63, no. 5, pp. 367–371, 2012. View at Google Scholar · View at Scopus
  10. I. M. Stratton, A. I. Adler, H. A. W. Neil et al., “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study,” British Medical Journal, vol. 321, no. 7258, pp. 405–412, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. P. G. Camici, “Microcirculation: what is the role of calcium antagonists?” European Heart Journal, vol. 18, pp. A51–A55, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. S. S. Abdelmoneim, A. Basu, M. Bernier et al., “Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography,” Diabetes and Vascular Disease Research, vol. 8, no. 4, pp. 254–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Wei, A. R. Jayaweera, S. Firoozan, A. Linka, D. M. Skyba, and S. Kaul, “Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion,” Circulation, vol. 97, no. 5, pp. 473–483, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Vogel, A. Indermühle, and J. Reinhardt, “The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation,” Journal of the American College of Cardiology, vol. 45, pp. 754–762, 2005. View at Publisher · View at Google Scholar
  15. A. Nitenberg, P. Valensi, R. Sachs, M. Dali, E. Aptecar, and J. Attali, “Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function,” Diabetes, vol. 42, no. 7, pp. 1017–1025, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Yokoyama, K. Yonekura, T. Ohtake et al., “Coronary microangiopathy in type 2 diabetic patients: Relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease,” Journal of Nuclear Medicine, vol. 41, no. 6, pp. 978–985, 2000. View at Google Scholar · View at Scopus
  17. UK Prospective Diabetes Study (UKPDS) Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patientsw ith type 2 diabetes (UKPDS 33),” The Lancet, vol. 352, pp. 837–853, 1998. View at Publisher · View at Google Scholar
  18. R. ten Brinke, N. Dekker, M. de Groot, and D. Ikkersheim, “Lowering HbA1c in type 2 diabetics results in reduced risk of coronary heart disease and all-cause mortality,” Primary Care Diabetes, vol. 2, no. 1, pp. 45–49, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. I. M. Stratton, C. A. Cull, A. I. Adler, D. R. Matthews, H. A. W. Neil, and R. R. Holman, “Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75),” Diabetologia, vol. 49, no. 8, pp. 1761–1769, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. I. Adler, I. M. Stratton, H. A. W. Neil et al., “Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study,” British Medical Journal, vol. 321, no. 7258, pp. 412–419, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Duckworth, C. Abraira, T. Moritz et al., “Glucose control and vascular complications in veterans with type 2 diabetes,” The New England Journal of Medicine, vol. 360, no. 2, pp. 129–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. G. Dluhy and G. T. McMahon, “Intensive glycemic control in the ACCORD and ADVANCE trials,” The New England Journal of Medicine, vol. 358, no. 24, pp. 2630–2633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Kishimoto, H. Makino, Y. Ohata et al., “Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic peptide level,” Diabetes Research and Clinical Practice, vol. 104, pp. 257–265, 2014. View at Google Scholar
  24. G. Cioffi, P. Faggiano, D. Lucci et al., “Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: the DYDA study,” Diabetes Research and Clinical Practice, vol. 101, no. 2, pp. 236–242, 2013. View at Publisher · View at Google Scholar · View at Scopus